Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000921895-25-000040·CAS Investment Partners, LLC
Schedule 13D ownership disclosure
CARDLYTICS INC
Common Stock, par value $0.0001 · CUSIP: 14161W105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CAS Investment Partners, LLCReported CIK 0001697591
Shares: 5,614,878.00 · Class: 11.0%
- SOSIN MASTER, LP
Shares: 3,425,395.00 · Class: 6.7%
- CSWR PARTNERS, LP
Shares: 2,189,483.00 · Class: 4.3%
- SOSIN LLC
Shares: 5,614,878.00 · Class: 11.0%
- SOSIN CLIFFORDReported CIK 0001697919
Shares: 5,614,878.00 · Class: 11.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000040
- Form type
- SCHEDULE 13D/A
- Filer
- CAS Investment Partners, LLC
- CIK
- CIK 1697591
- Filed
- Jan 03, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13D beneficial ownership